SELB
Income statement / Annual
Last year (2023), Selecta Biosciences, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Selecta Biosciences, Inc.'s net income was -$219.71 M.
See Selecta Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00 |
$110.78 M |
$85.08 M |
$16.60 M |
$6.68 M |
$903,000.00 |
$207,000.00 |
$8.08 M |
$6.01 M |
$3.04 M |
| Cost of Revenue |
$0.00
|
$72.38 M
|
$68.74 M
|
$54.51 M
|
$42.74 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$38.40 M
|
$16.34 M
|
-$37.91 M
|
-$36.07 M
|
$903,000.00
|
$207,000.00
|
$8.08 M
|
$6.01 M
|
$3.04 M
|
| Gross Profit Ratio |
0
|
0.35
|
0.19
|
-2.28
|
-5.4
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$71.84 M
|
$72.38 M
|
$68.74 M
|
$54.51 M
|
$42.74 M
|
$47.69 M
|
$45.17 M
|
$29.70 M
|
$22.98 M
|
$10.49 M
|
| General & Administrative Expenses |
$40.58 M
|
$23.86 M
|
$20.94 M
|
$18.91 M
|
$16.39 M
|
$18.24 M
|
$18.83 M
|
$13.05 M
|
$8.34 M
|
$7.95 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$40.58 M
|
$23.86 M
|
$20.94 M
|
$18.91 M
|
$16.39 M
|
$18.24 M
|
$18.83 M
|
$13.05 M
|
$8.34 M
|
$7.95 M
|
| Other Expenses |
$0.00
|
$330,000.00
|
$15,000.00
|
$89,000.00
|
-$1.31 M
|
$10,000.00
|
-$152,000.00
|
$4,000.00
|
-$26,000.00
|
-$44,000.00
|
| Operating Expenses |
$112.42 M
|
$96.24 M
|
$89.67 M
|
$73.42 M
|
$59.13 M
|
$65.93 M
|
$63.99 M
|
$42.75 M
|
$31.32 M
|
$18.44 M
|
| Cost And Expenses |
$112.42 M
|
$96.24 M
|
$89.67 M
|
$73.42 M
|
$59.13 M
|
$65.93 M
|
$63.99 M
|
$42.75 M
|
$31.32 M
|
$18.44 M
|
| Interest Income |
$0.00
|
$958,000.00
|
$2.80 M
|
$1.30 M
|
$834,000.00
|
$1.05 M
|
$617,000.00
|
$234,000.00
|
$171,000.00
|
$111,000.00
|
| Interest Expense |
-$2.83 M
|
$3.03 M
|
$2.84 M
|
$1.56 M
|
$1.52 M
|
$1.49 M
|
$1.21 M
|
$1.25 M
|
$948,000.00
|
$552,000.00
|
| Depreciation & Amortization |
$764,000.00
|
$1.62 M
|
$15,000.00
|
$89,000.00
|
-$1.31 M
|
$975,000.00
|
$750,000.00
|
$802,000.00
|
$1.04 M
|
$864,000.00
|
| EBITDA |
-$86.42 M |
$16.16 M |
-$4.58 M |
-$56.73 M |
-$53.76 M |
-$65.01 M |
-$63.94 M |
-$34.67 M |
-$24.29 M |
-$14.58 M |
| EBITDA Ratio |
0
|
0.15
|
-0.05
|
-3.42
|
-8.05
|
-72
|
-308.87
|
-4.29
|
-4.04
|
-4.8
|
| Operating Income Ratio |
0
|
0.13
|
-0.05
|
-3.42
|
-7.86
|
-72.01
|
-308.14
|
-4.29
|
-4.21
|
-5.07
|
| Total Other Income/Expenses Net |
-$152.29 M
|
$20.23 M
|
-$5.12 M
|
-$12.06 M
|
-$2.90 M
|
-$314,000.00
|
-$1.54 M
|
-$1.54 M
|
$130,000.00
|
$2.52 M
|
| Income Before Tax |
-$238.71 M
|
$34.77 M
|
-$9.72 M
|
-$68.88 M
|
-$55.35 M
|
-$65.34 M
|
-$65.32 M
|
-$36.21 M
|
-$25.17 M
|
-$12.88 M
|
| Income Before Tax Ratio |
0
|
0.31
|
-0.11
|
-4.15
|
-8.29
|
-72.35
|
-315.56
|
-4.48
|
-4.19
|
-4.24
|
| Income Tax Expense |
$19.00 M
|
-$609,000.00
|
$15.97 M
|
$911,000.00
|
-$1.81 M
|
$1.18 M
|
$304,000.00
|
$455,000.00
|
$922,000.00
|
$508,000.00
|
| Net Income |
-$219.71 M
|
$35.38 M
|
-$25.69 M
|
-$69.79 M
|
-$53.54 M
|
-$65.34 M
|
-$65.32 M
|
-$36.21 M
|
-$25.17 M
|
-$12.88 M
|
| Net Income Ratio |
0
|
0.32
|
-0.3
|
-4.2
|
-8.02
|
-72.35
|
-315.56
|
-4.48
|
-4.19
|
-4.24
|
| EPS |
-0.0014 |
0.24 |
-0.22 |
-0.69 |
-1.18 |
-2.92 |
-3.2 |
-3.45 |
-1.96 |
-1 |
| EPS Diluted |
-0.0014 |
0.1 |
-0.22 |
-0.69 |
-1.18 |
-2.92 |
-3.2 |
-3.45 |
-1.96 |
-1 |
| Weighted Average Shares Out |
$155.11 B
|
$144.76 M
|
$114.33 M
|
$101.20 M
|
$45.55 M
|
$22.39 M
|
$20.43 M
|
$10.49 M
|
$12.87 M
|
$12.87 M
|
| Weighted Average Shares Out Diluted |
$155.11 B
|
$145.87 M
|
$114.33 M
|
$101.20 M
|
$45.55 M
|
$22.39 M
|
$20.43 M
|
$10.49 M
|
$12.87 M
|
$12.87 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
